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Lung density in the trajectory path — a strong indicator of 
patients sustaining a pneumothorax during CT-guided lung biopsy
Abstract
Introduction: The purpose is to evaluate the prognostic significance of lung parenchymal density during percutaneous coaxial 
cutting needle lung biopsy (PNLB). 
Materials and methods: Retrospective analysis of 179 consecutive patients (106 males, 73 females; mean age 59.16 ± 16.34 
years) undergoing PNLB was included. Mean lobar parenchymal lung density, mean densities anterior to the lesion and posterior 
to the chest wall in the needle trajectory path were measured in HU. Lesion location and needle trajectory were also measured. 
Fisher’s exact test and Chi-square test were conducted to analyze the categorical variables. ANOVA test was done to examine 
continuous and normally distributed variables. Statistical significance was considered when p < 0.05. 
Results: Mean lobar parenchymal lung density (p < 0.05) and mean parenchymal lung density relative to the needle trajectory 
path were below -800 HU in patients who sustained a pneumothorax. Increase in the number of pleural passes was significantly 
associated with the risk of patients having pneumothorax (p < 0.05). The mean distance from the skin to the lesion and needle 
trajectory angle were not statistically different among patients with and without pneumothorax (p > 0.05). 
Conclusion: Lobar parenchymal density and lung parenchymal density anterior to the lesion and posterior to the chest wall in 
the needle trajectory path could be used as predicting parameters in patients undergoing PNLB who sustained a pneumothorax. 
These findings can help interventional radiologist further assess risk of pneumothorax when preforming such procedure. 
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Introduction
Percutaneous computed tomography (CT) 
guided needle pulmonary lesion biopsy is an ef-
fective and safe method for the diagnosis of lung 
nodules. In order to facilitate repeat sampling 
and decrease procedural duration, the coaxial 
technique for percutaneous lung lesion biopsy 
can be used. This method achieves all the afo-
rementioned objectives without increasing the 
number of passes through the pleura [1]. Thus, 
percutaneous coaxial cutting needle lung biopsy 
(PNLB) has replaced open surgical biopsies as the 
gold standard for obtaining tissue samples from 
intraparenchymal lung masses to establish an 
accurate pathological diagnosis. The American 
College of Radiology and Society of Interventional 
Radiology have reported that there are no absolute 
contraindications that are addressed prior to PNLB 
[1]. However, there are relative contraindications 
for PNLB, including, but not limited to significant 
coagulopathy, compromised cardiopulmonary 
function, lack of a safe pathway to the lesion, an 
inability of the patient to cooperate with positio-
ning and instruction, and pregnancy. Neverthe-
less, success rates are affected by many variables. 
The success rates in many quality improvement 
task forces are reliant on a combination of factors 
such as interventionist skill set, years of experien-
ce and rate of complications post PNLB. 
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One important complication of PNLB is 
pneumothorax. Pneumothorax is reported to 
occur in 17 to 26.6% of patients, with 1 to 14.2% 
requiring chest tube insertion [2]. Risk factors for 
pneumothorax during PNLB include as follows: 
patient’s age [3], greater lesion depth [4], lower 
lobe lesion [5], needle trajectory angle less than 
45 degrees [3, 5, 6], lesion size [7], increased 
number of pleural passes [8] and radiographic 
emphysema [9]. 
This study aims to evaluate the possibility 
that lobar lung parenchymal density and lung 
parenchymal density relative to the trajectory 
path are linked to an increased risk of pneumotho-
rax during PNLB. The primary end point of the 
study is to evaluate the ability of interventional 
radiologists to assess parenchymal lung density 
accurately as a quantitative specific threshold in 
predicting pneumothorax in patients undergoing 
PNLB. A secondary end point is to evaluate which 
factors related to the patient, the lesion, or the 
techniques of PNLB act as a strong indicator for 
pneumothorax. Such findings may be relevant to 
formulating a model that aids in assessing risks 
quantitatively, prior to intervention. 
Materials and methods
Inclusion and exclusion criteria
The retrospective study included 179 pa-
tients (106 males and 73 females) who underwent 
CT-guided percutaneous lung biopsies and were 
classified according to a lung biopsy technique. 
Exclusion criteria were the following: lesion 
< 5 mm diameter, uncorrectable coagulopathy, 
positive pressure ventilation, severe respiratory 
compromise, pulmonary arterial hypertension, 
and incapacity to follow instructions or refusal of 
the procedure. The study had full IRB approval. 
Region of interest measurements
One expert in medical imaging (C.S.) me-
asured the attenuation of lung parenchyma and 
lesion in all 179 patients. Lung parenchymal 
attenuation that was in the trajectory path of the 
needle (Figure 1) was determined by placing the 
routinely used region of interest (ROI) within 
the lung segments of greatest dimension in the 
transaxial plane and was calculated by using the 
average measurement over three ROI. Attenuation 
was measured at the level of each angle (I–V), 
then the average measurement was taken to cal-
culate lung parenchymal attenuation anterior to 
the lesion and posterior to the chest wall as per 
Figure 1. Total lobular parenchymal density was 
calculated employing an automated dedicated 
lung density software (Intellispace, 5.0, Philips 
Healthcare, Best, The Netherlands) to determine 
the mean attenuation of the lung parenchyma in 
each lobe of the lung. 
Biopsy protocol
Informed consents were obtained from all 
patients prior to the lung biopsy. Coagulation 
parameters of all subjects were checked to ensure 
platelet counts > 50,000/mL and an international 
normalized ratio < 1.5 as recommended in consen-
sus guidelines [10]. All patients had chest CT scans 
that were checked and cross-referenced with the 
referring physician and the patient history, prior 
to the procedure. The scan parameters prior to the 
biopsy were the following: detector width 256 × 
0.625 mm; pitch 1.1; rotation time 0.4 sec; exposure 
factors 100 kVp, 200 mA, with z-axis modulation; 
and a scanning time of 2.1 sec. The patients were 
then positioned in the prone, supine, or lateral 
decubitus position on the basis of the location of 
the target lesion to minimize the number of pleural 
reflections, avoid major fissures, predetermine the 
needle trajectory, the shortest distance to the lesion, 
and the amount of crossed lung parenchyma . The 
study subjects were instructed to take a reprodu-
cible breath inspiration and abstain from talking 
during scans, needle positioning, and sampling. 
The localizing CT scan was used to determine the 
position of the target lesion. 
By using sterile technique, local anesthesia 
was employed with 1% lidocaine. A small sub-
cutaneous incision was made for needle entry, 
and a 16-gauge guiding needle was placed to 
the thoracic wall just proximal to the pleura. 
Subsequently, the pleura was passed with a sin-
gle puncture (Quick Core, Cook, USA), and the 
needle was placed into the lesion. Then, the inner 
Figure 1. Lung parenchyma density within the trajectory angle from 
the chest wall
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part (stylet) of the biopsy needle was removed and 
the orifice of the needle was water sealed using 
normal saline while asking the patient to hold 
his breath. Then, the 18-gauge cutting needle 
was inserted into the lesion over the introducer. 
All PNLB was performed by 4 interventional ra-
diologists with a mean of 17 years of experience.
Limited CT scan was obtained of each patient 
that underwent lung biopsy to identify complica-
tions such as pneumothorax and bleeding. If the 
pneumothorax was confined and not symptoma-
tic, a repeat limited CT scan was taken 2 hours 
post biopsy. If on repeat scan, the pneumothorax 
was stable, the patients with normal vital signs 
were sent home with safety instructions. If the 
pneumothorax increased and/or the patients 
became unstable, an 8 French pleural drain was 
placed, and the patient was admitted to hospital 
for 24 hours. 
Statistical analysis
Statistical analysis was performed using SPSS 
(statistical package for social sciences, version 21, 
SPSS Inc., Chicago, IL, USA). Fisher’s exact test, 
and Chi-square test were conducted to analyze the 
categorical variables. Fisher’s exact test was done 
when the sample size within the categories was 
very minimal (i.e. when comparing lesion lobes 
and needle angles). Using the central tendency 
theorem stating that when the sample size is 
greater than 30 patients, the non-normally distri-
buted variables are considered normal , we were 
able to conduct ANOVA test. The tested variables 
were gender, age, smoking status, the number of 
pleural passes, the distance from the skin and the 
chest wall, lung density posterior to the chest wall 
and anterior to the lesion, lung density relative 
to the needle trajectory (Figure 1) and total lobar 
parenchymal lung density. Lung lesion density 
ratio was compared between each group and the 
ratio of lobar lung density to lesion density was 
calculated. Logistic regression approach was im-
plemented to conduct bivariate and multivariate 
analysis to assess the crude and adjusted odds 
ratios of the risk of having a pneumothorax. Only 
variables that showed statistical significance 
of having pneumothorax on the bivariate level 
with a p-value less than 0.2 were included in the 
multivariate analysis. Results with a p-value less 
than 0.05 were considered statistically significant.
Study protocol
A single investigator, who was an expert 
in medical imaging and was not included in 
the proper study, reviewed clinical records of 
each patient. All technical parameters were 
measured and the lung attenuation values em-
ployed an ROI of 2 mm. Lung density, lesion 
characteristics (location, size measured in 
greatest transverse diameter, and depth from 
the pleura along the biopsy track, if the lesion 
abutted the pleural surface), and the presence 
of a  lung fissure or blood vessel intersecting 
the biopsy path were assessed and recorded 
(Figure 1). 
Results 
Patients’ demographics
During the study period, 179 consecutive 
patients fulfilled the inclusion criteria and under-
went image-guided lung biopsy at our institution. 
The mean age of males (61.58 ± 15.53 years) 
demonstrated a statistical difference compared 
to that of females (55.55 ±16.97) (p < 0.014). 
Whereas, the mean age of smokers (60.77 ± 15.03) 
was not statistically different from that of non-
-smokers (57.89 ± 17.24; p < 0.247). 
Of the 179 lung lesions, 48 (27 %) were loca-
ted in the right upper lobe, 17 (9%) in the right 
middle lobe, 27 (15%) in the right lower lobe, 
47 (26%) in the left upper lobe, 29 (16%) in the 
left lower lobe, and 11 (7%) within the media-
stinum. Malignant and benign lesions were dia-
gnosed in 138 and 15 patients, respectively, with 
26 non-diagnostic sample. The final diagnosis was 
adenocarcinoma (n = 55), small-cell carcinoma 
(n = 16), squamous cell carcinoma (n = 23), 
large-cell carcinoma (n = 12), lymphoma (n = 7) 
and metastatic tumors (n = 45).
Lung parenchymal characteristics and 
lung lesion density ratio
The lobar parenchymal lung density in 
all patients with pneumothorax demonstrated 
a threshold lower than -800 HU (increased aera-
tion and reduced lung density), which included 
the segmental range (I  – IV; 0–180°; Figure 1) 
of the needle trajectory (Table 1). Average lung 
density anterior to the mass and posterior to the 
chest wall showed an overall decrease in the 
subjects with pneumothorax compared to the 
patients without pneumothorax with varying 
significance. Significant decrease was noted at 
the right upper lobe (p < 0.02) and left upper 
lobe (p < 0.02). 
Additionally, mean lesion density did not 
differ between both groups (Table 1). Finally, the 
lung (anterior to the lesion and posterior to the 
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Table 1. Mean lobar lung parenchymal density among the patients with and without pneumothorax
Pneumothorax Yes
N = 79
No
N =100
P-value
Right lung
 Right upper lobe -831.95 ± 52.03 -791.41 ± 51.88 < 0.001
 Right middle lobe -830.15 ± 54.05 -792.94 ± 59.69 < 0.001
 Right lower lobe -823.52 ± 67.48 -757.08 ± 58.97 < 0.011
Left lung
 Left upper lobe -830.21 ± 53.36 -786.82 ± 58.97 < 0.001
 Left lower lobe -817.31 ± 75.88 -756.45 ± 172.10 < 0.030
Note: (±) is standard deviation
Table 2.  Mean lung density anterior to the lesion and posterior to the chest wall, mean lesion density, and lung to lesion 
tissue ratio among the patients with and without pneumothorax 
Pneumothorax Lung density anterior to the lesion Lesion density Ratio
Yes No P-value Yes No P-value Yes No
Right lung
 Right upper lobe -819.4 ± 45.90 -768.9 ± 80.13 0.02 37.41 ± 15.93 36.26 ± 14.15 0.80 1.31 1.29
 Right middle lobe -841.0±42.90 -800.93 ± 47.90 0.10 38.59 ± 14.76 31.27 ± 23.17 0.44 1.13 4.17
 Right lower lobe 747.87± 156.12 -782.10 ± 65.90 0.47 31.26 ± 12.40 30.16 ± 15.94 0.84 1.22 1.59
Left lung
 Left upper lobe -830.05±61.70 -777.18 ± 48.67 0.02 32.28 ± 18.71 32.45 ± 20.29 0.98 1.14 1.24
 Left lower lobe -799.26±97.84 -755.55 ± 110.22 0.27 37.08 ± 14.02 35.73 ± 16.99 0.82 1.16 1.41
 Mediastinal -811.05±75.65 -725.15 ± 147.55 0.15 39.85 ± 12.33 42.71 ± 7.42 0.58 1.10 1.048
Note: (±) is standard deviation 
chest wall) to lesion density ratio in the patients 
with pneumothorax ranged from 1.24 to 4.14, 
compared to a narrower range from 1.1 to 1.3 
in individuals who sustained a pneumothorax 
(Table 2). This study suggests a possible risk of 
pneumothorax in patients with a lung to lesion 
ratio less than 1.3.
Lung parenchymal density relative to the 
needle trajectory
The mean lung density relative to needle 
trajectory in the patients with pneumothorax was 
lower than -800 in all five angles (0–180°; Table 
3). Mean lung densities of 135° and 180° relative 
to trajectories showed statistically significant 
difference between the subjects with and without 
pneumothorax (p < 0.001 and p < 0.012, respec-
tively). Although there was no statistically signi-
ficant difference for the other angles (p > 0.05), 
all had a mean lung parenchymal threshold below 
-800 HU, which is compatible with the results 
shown in Table 1. This finding was irrespective 
of the trajectory needle angle. 
Needle entry, trajectory, depth and 
distance characteristics
The mean of the number of pleural passes 
in the patients with and without pneumothorax 
was 2.61 ±1.85 and 1.95 ± 1.234, respectively, 
which was not statistically significant (p < 0.061). 
Needle trajectory angle showed no statistical 
significance (p = 0.79). The majority of needle 
angles fell within 0 to 45 degrees (Table 3). 
The total mean distance from the chest 
was statistically significant comparing the pa-
tients with versus those without pneumothorax 
(p < 0.032). This was not the case when we were 
looking at the total mean distance from the skin 
(p < 0.823; Table 3). There was no statistical signi-
ficance between lesion lobes and lesion depth for 
both populations nor between depth and having 
pneumothorax in each lesion lobe (p > 0.05). 
Bivariate and multivariate analyses of 
risk of having pneumothorax
At the bivariate logistic regression level, 
smoking status, the mean distance from the chest 
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Table 3.  Needle trajectory angle, lesion lobes and distance characteristics among the patients with and without 
pneumothorax
Pneumothorax Yes
N = 79
No
N =100
P-value
Needle angle 
  0–45 ° 72 80 0.791
  46–90 ° 6 17
  91–135° 1 3
Mean lung density relative to needle trajectory
 0° left -806.89 ± 194.71 -780.46 ± 78.87  0.211
 45° middle left -801.86 ± 200.35 -771.17 ± 94.22  0.172
 90° perpendicular to pleura -804.38 ± 112.19 -791.96 ± 81.22  0.232
 135° middle right -810.48 ± 79.58 -764.75 ± 111.47  0.001
 180° right  -811.39 ± 117.70 -763.76 ± 119.44  0.012
Mean distance from skin 0.281
Right lung
 Right upper lobe
60.07 ± 17.902 55.34 ± 20.683
 Right middle lobe 56.32 ± 17.521 51.98 ± 21.161
 Right lower lobe 56.25 ± 20.634 55.57 ± 18.892
Left lung
 Left upper lobe
48.93 ± 13.134 59.64 ± 20.131
 Left lower lobe 55.42 ± 23.472 60.28 ± 17.397
 Mediastinal 57.26 ± 36.421 41.11 ± 20.702
Total 55.3 ± 20.842 55.97 ± 20.023 0.823
Mean distance from chest wall 0.836
Right lung
 Right upper lobe 20.36 ± 13.382 11.63 ± 12.784
 Right middle lobe 15.47 ± 13.025 10.07 ± 14.418
 Right lower lobe 17.14 ± 18.866 10.85 ± 13.816
Left lung
 Left upper lobe
13.04 ± 11.53 13.72 ± 17.409
 Left lower lobe 18.83 ± 19.02 16.31 ± 19.174
 Mediastinal 18.33 ± 24.521 4.19 ± 9.921
Total 17.02 ± 16.199 12.06 ± 15.202 0.032
Number of passes 2.61 ± 1.85 1.95 ± 1.234 0.061
Note: (±) is standard deviation
wall, and the number of pleural passes were 
significantly associated with the risk of having 
pneumothorax (p < 0.05). For instance, smokers 
were 2.75 times more liable to have pneumotho-
rax compared to non-smokers (OR = 2.75; 95%CI: 
1.51–5.03). Whereas, age, gender, lesion depth 
and lesion lobes were not statistically significant 
with the risk of having pneumothorax (p > 0.05; 
Table 4).
Whereas at the multivariate logistic regres-
sion level, adjusting for age and gender, smoking 
status and the number of pleural passes remained 
in statistically significant association with the risk 
of having pneumothorax: smokers were 2.67 times 
more prone to having pneumothorax compared 
to non-smokers (OR = 2.67; 95%CI: 11.39–5.15). 
With every unit growth in the number of pleural 
passes, the odds of having pneumothorax incre-
ased multiplicatively by 1.33 folds (OR = 1.33; 
95%CI: 1.69). However, the mean distance from 
the chest wall was not associated with the risk 
of having a pneumothorax (p = 0.39). Moreover, 
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Table 4. Bivariate and multivariate analyses of risk of having pneumothorax and other covariates showing adjusted ORs 
Bivariate analysis Multivariate analysis
Variables OR 95%CI OR P-value OR 95%CI OR P-value
Age 1.01 0.99–1.02 0.62 1 0.98–1.02 0.92
Gender    
 Male Reference 0.45 Reference 0.78
 Femalez 0.79 0.44–1.44 0.91 0.46–1.79
Smoking status    
 No Reference 0.001 Reference 0.003
 Yes 2.75 1.51–5.03 2.67 1.39–5.15
Mean distance from chest wall 1.05 1.00–1.1 0.04 1.01 0.99–1.04 0.39
Mean number of passes 1.34 1.08–1.66 0.007 1.33 1.05–1.69 0.02
Mean lesion depth    
Peripheral Reference 0.12 Reference 0.23
Central 2.33 1.04–5.21 0.04 2.16 0.83–5.65 0.12
Deep 1.14 0.55–2.36 0.71 0.98 0.38–2.54 0.96
Lesion lobes    
Left lung    
 Left upper lobe Reference 0.33  
 Left lower lobe 2.05 0.80–5.233 0.13  
Right Lung    
 Right upper lobe 1.09 0.48–2.49 0.83  
 Right middle lobe 3.06 0.96–9.69 0.06  
 Right lower lobe 1.44 0.56–3.72 0.45  
Mediastinal 1.88 0.61–5.73 0.27  
Types of lung lesions    
Benign Reference 0.23  
Malignant 0.56 0.19–1.66  
CI — confidence interval; OR — is odds ratio
lesion depth remained unassociated with the risk 
of having pneumothorax (p > 0.05; Table 4).
Discussion 
The decision to perform PLNB depends on 
the site of the abnormality, the performance 
status, the co-morbidities, and how much of an 
impact the procedure will carry in terms of ma-
nagement. In the literature, there is insufficient 
data on the ability of radiologists and other cli-
nicians to predict the occurrence of iatrogenic 
pneumothorax [9]. Previous studies have reported 
an increased risk of pneumothorax with lesion 
depth, angle of trajectory, and visually assessed 
emphysema on chest CT [9, 11–14]. Our findings 
suggest that although radiologists can predict 
the proportion of pneumothorax occurring in 
a cohort of patients, they are unable to do this in 
an individual case. To the best of our knowledge, 
this is the first study aiming to evaluate the quan-
titative lung parenchymal density and the risk of 
pneumothorax when performing PLNB. 
Previously reported studies demonstrated 
a significant increase in pneumothorax rates from 
13% for lesions abutting the pleural surface to 
29% for lesions where the needle traverses the 
aerated lung, which is likely due to the decreased 
stability of the needle in a short intrapulmonary 
course leading to pleural tears [15]. Another study 
demonstrated that higher rates of pneumotho-
rax were associated with needle paths greater 
than 4 cm [16]. Additionally, the interventional 
radiologist experience is the third major risk 
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factor for pneumothorax. The incidence rate of 
pneumothorax among experienced radiologists 
was 17% compared to 30% among unexperienced 
ones [15]. Our study demonstrated that overall 
lobar parenchymal density below -800 HU was 
associated with having pneumothorax. Also, we 
showed that lower lung densitities (less then 
-800 HU) relative to needle trajectory (0° to 180° 
anterior to the lesion and posterior to the chest 
wall) are associated with having pneumothorax. 
Adding to the current literature and data, quanti-
fication of the lung parenchyma in the trajectory 
path of the biopsy could further reduce the rate 
of pneumothorax during PNLB.
Other suggested risk factors for pneumotho-
rax during PNLB include smoking, older age, 
needle thickness, biopsy needle angle, lesion 
position, lesion volume and distance from the 
pleura to the tumor [17]. In our study, initial 
bivariate analysis showed that pneumothorax 
was associated with a positive smoking history, 
increased mean distance from the chest wall, and 
the higher number of pleural passes. However, 
when we adjusted for age and gender, the mean 
distance from the chest wall was not associated 
with having a pneumothorax. Moreover, age was 
not linked to an increased risk of pneumothorax, 
which is not compatible with the current literatu-
re [17]. Finally, gender, lesion depth (peripheral, 
central or deep) and lesion lobes were not asso-
ciated with having pneumothorax.
There were shortcomings in our study. First, 
the retrospective design of the research made it 
difficult to determine the clinical indication for 
ordering a  lung biopsy in each patient accura-
tely. Also, for reasons such as lack of follow-up, 
final results from surgical pathology or autopsy 
were not available to confirm a benign or mali-
gnant etiology for all of the non-diagnostic core 
biopsies. Second, the relationship between the 
distance of a target from the diaphragm and the 
likelihood of a diagnostic success on the basis 
of the etiology of the lesion was not addressed. 
Third, our study did not measure the associated 
post-biopsy complication rates such as bleeding, 
infection and clinical outcome. Finally, there was 
no comparison between operators.
Conclusions
Pneumothorax is still a major issue in PNLB 
with a myriad of risk factors. This is the first 
study to investigate and prove that the density of 
lobar lung parenchyma and parenchyma anterior 
to the lesion and relative to the needle trajectory 
path could be used as parameters in predicting 
pneumothorax in patients undergoing percuta-
neous coaxial cutting needle biopsy. This finding 
can help interventional radiologist further assess 
risk of pneumothorax when preforming such 
procedure. 
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